관상동맥질환 영상진단기기 시장, 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2024-2032년)

The Global Coronary Heart Disease Diagnostic Imaging Devices Market share recorded USD 1.8 billion in 2022 and will exhibit a growth rate of 6.6% between 2024 and 2032, fueled by the increasing prevalence of coronary heart disease (CHD) and the growing demand for early diagnosis and prevention. As CHD rates rise globally, there is a heightened need for advanced imaging technologies to detect the condition at early stages. Early diagnosis allows for timely intervention, reducing the risk of severe outcomes. This focus on proactive healthcare drives demand for sophisticated diagnostic imaging devices, thereby expanding the market as healthcare systems prioritize effective and early detection solutions.

The overall coronary heart disease diagnostic imaging devices industry is segmented based on modality, application, end-use, and region.

The computed tomography (CT) segment will accumulate USD 443.8 million by 2032 due to its superior imaging capabilities and precision. CT scans provide detailed cross-sectional images of the heart and blood vessels, enabling accurate diagnosis of coronary artery disease and assessment of plaque buildup. The technology's ability to quickly produce high-resolution images makes it a preferred choice for clinicians seeking reliable and efficient diagnostic tools. As demand for detailed cardiac imaging increases, the CT segment will dominate the market.

The heart attack segment captured USD 585.7 million in 2023, attributed to the critical need for rapid and accurate diagnosis in acute scenarios. Timely identification of heart attacks is crucial for effective treatment and improved patient outcomes. Diagnostic imaging devices, such as CT and MRI, play a key role in assessing the extent of heart damage and guiding interventions. As the prevalence of heart attacks continues to rise, the demand for advanced imaging solutions in this segment will drive significant market growth.

The U.S. coronary heart disease diagnostic imaging devices market will reach USD 1.3 billion by 2032, owing to its advanced healthcare infrastructure, high prevalence of coronary heart disease, and substantial investments in medical technology. The country's robust healthcare system and high adoption rates of cutting-edge diagnostic tools, including advanced imaging technologies, drive market growth. Additionally, the U.S. benefits from ongoing research and development efforts, making it a key contributor to the expansion and innovation in the coronary heart disease diagnostic imaging devices industry.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of coronary heart disease
    • 3.2.1.2 Advancements in diagnostic imaging technology
    • 3.2.1.3 Growing awareness and early diagnosis of coronary heart disease
    • 3.2.1.4 Growing demand for non-invasive diagnostic tools
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of imaging devices
    • 3.2.2.2 Lack of skilled professionals
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
  • 3.5.1 Core technologies
  • 3.5.2 Adjacent technologies
• 3.6 Gap analysis
• 3.7 Future market trends
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Computed tomography (CT)
• 5.3 X-ray
• 5.4 Ultrasound
• 5.5 Magnetic resonance imaging(MRI)
• 5.6 Nuclear medicine

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Arrhythmia
• 6.3 Heart attack
• 6.4 Heart failure
• 6.5 Congenital heart conditions
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Diagnostic imaging centers
• 7.4 Ambulatory surgical centers (ASCs)
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Canon Inc.
• 9.2 Carestream Health
• 9.3 CHISON Medical Technologies Co., Ltd.
• 9.4 Esaote SPA
• 9.5 FUJIFILM Holdings Corporation
• 9.6 GE HealthCare Technologies Inc.
• 9.7 Koninklijke Philips N.V.
• 9.8 Neusoft Corporation
• 9.9 Samsung Electronics Co., Ltd.
• 9.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 9.11 Shimadzu Corporation
• 9.12 Siemens Healthineers AG
• 9.13 Ziehm Imaging GmbH